What blunting is, and what it is not
Blunting is a reduction in the intensity of emotional experience — both unpleasant and pleasant. Patients describe it in clinical literature as feeling "functional but not fully there", less reactive but also less able to feel love, joy, or grief at the depth they used to. The Royal College of Psychiatrists and Maudsley Prescribing Guidelines describe blunting as distinct from depression itself.
A flattening of feeling intensity — both highs and lows are muted. Energy and function may be largely intact. Mood is not low in the classical depressive sense; it is simply quieter than before.
Characterised by low mood, anhedonia (loss of interest or pleasure), energy loss, and often hopelessness. The absence of feeling is accompanied by a negative quality — not neutral flatness, but an active sense of emptiness or heaviness.
They can co-occur but are different phenomena, and a prescriber can usually help distinguish them — especially with a written record across several weeks.
How common blunting is, according to the literature
Why blunting happens
The mechanism is not fully resolved in the scientific literature. The most-supported explanation, discussed in psychiatric reviews and the Maudsley Prescribing Guidelines, is that increased serotonin availability quiets activity in brain regions that produce emotional intensity — including those producing positive emotion. This is a consequence of the same mechanism that reduces the intensity of depressive experience. Other contributing factors — dose, individual neurobiology, length of treatment — are all areas of active research.
Whether blunting tends to ease
Clinical descriptions in the Royal College of Psychiatrists patient resources and RANZCP guidance describe blunting as variable: for some patients it is most prominent in the first months and softens as treatment continues; for others it persists throughout treatment. There is no reliable individual predictor of which group a person will be in. A clear written record of how feelings feel over six to eight weeks helps you and your prescriber assess the trade-off accurately — without relying on memory alone, which is especially unreliable during a period of mood treatment.
Conversations worth having with your prescriber
Whether a small dose reduction is reasonable to trial. Some patients experience meaningful improvement in blunting at a slightly lower dose without losing therapeutic effect — a documented strategy in Maudsley Prescribing Guidelines. This is a decision to make with your prescriber, not on your own.
Whether a switch to a different medication is worth considering. Different antidepressants have different blunting profiles — this variation is documented in major prescribing resources. Switching specifically to address blunting is a recognised clinical option.
Whether augmentation strategies are appropriate. These are more specialist conversations and typically involve a psychiatrist rather than a GP — but they are a real part of the clinical landscape for people who need to stay on an effective medication while addressing its side effects.
Whether the trade-off remains worth it. This is ultimately your decision, made with your prescriber. Blunting affects quality of life in ways that are real and worth naming explicitly — not something to mention apologetically at the end of an appointment.
Frequently asked questions
Is emotional blunting the same as feeling depressed again?+
No. Clinical descriptions including the Royal College of Psychiatrists distinguish blunting (a flattening of feeling intensity) from a return of depression (characterised by low mood, anhedonia, and energy loss). They can co-occur but are different phenomena. A prescriber can usually help distinguish them, especially with a written record across several weeks.
Will lowering the dose help with blunting?+
For some patients a small dose reduction reduces blunting without losing therapeutic effect. This is a documented strategy in Maudsley Prescribing Guidelines but is a decision to make with your prescriber, not independently — abrupt dose changes can produce discontinuation symptoms and should always be guided by the prescriber who knows your history.
Are some antidepressants less likely to cause blunting?+
Yes — different antidepressants have different profiles. Comparative blunting effects are discussed in Maudsley Prescribing Guidelines and major psychiatric reviews. Switching medications specifically to address blunting is a conversation to have with your prescriber, who can weigh it against your history and response to the current medication.
Evidence and sources referenced
- Royal College of Psychiatrists — patient information on antidepressants and emotional effects
- Maudsley Prescribing Guidelines in Psychiatry — comparative blunting profiles and dose strategies
- RANZCP — Clinical Practice Guidelines for Mood Disorders
- NPS MedicineWise — patient resources on antidepressant side effects
- Peer-reviewed psychiatric reviews of emotional blunting prevalence and mechanism
Related articles
Want a structured way to track blunting alongside other patterns?
Causiq is being built to help you track the first 90 days simply — so you walk into your next appointment with a clear, honest picture of how you've actually been feeling.
Join the waitlist →